StockData
Oncotelic Therapeutics, Inc. logo

Oncotelic Therapeutics, Inc. (OTLC) stock

OTLCOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.02+0.00 (+11.45%)

Close on Oct 19, 2026Market cap $8.66MP/E 0.0Yield –

Oncotelic Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Oncotelic Therapeutics

Oncotelic Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Oncotelic Therapeutics figures

See a number that looks wrong?